Compounds for use in the treatment of mycobacterial infections: a patent evaluation (WO2014049107A1)

Expert Opinion on Therapeutic Patents
Dany Pechalrieu, Marie Lopez

Abstract

Tuberculosis is one of the main causes of mortality with 1.5 million deaths a year worldwide. The growing emergence of multi- and extremely resistant strains highlights the urgent need of novel antibiotic strategies. Ethionamide, interfering with the mycobacterial membrane biosynthesis, is used in second-line treatment. This molecule is a prodrug, which requires activation by EthA. The patent described in this evaluation (WO2014049107A1) claimed a new family of molecules and their use as antibiotic treatment against mycobacteria such as Mycobacterium tuberculosis, M. leprae and atypical mycobacteria, either as a single active agent or in combination with antibiotics activable by EthA pathway.

References

Jun 1, 1992·Antimicrobial Agents and Chemotherapy·A QuémardC Lacave
Aug 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·A E DeBarberC E Barry
Apr 6, 2001·Revue Scientifique Et Technique·W W Barrow
Feb 2, 2002·The Journal of Biological Chemistry·Tommaso A VannelliPaul R Ortiz de Montellano
Mar 22, 2002·Nature Reviews. Immunology·S H Kaufmann
Jun 7, 2003·Journal of Clinical Microbiology·Elvira RichterStefan Niemann
Nov 26, 2003·Antimicrobial Agents and Chemotherapy·Glenn P MorlockRobert C Cooksey
Mar 24, 2004·Nature Reviews. Microbiology·Graham R StewartDouglas B Young
Aug 11, 2004·Analytical Biochemistry·Mei-Chu LoGeorge Ellestad
Mar 21, 2006·Lancet·Mario C Raviglione, Mukund W Uplekar
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
Apr 7, 2007·Current Opinion in Pulmonary Medicine·Jennifer Furin
Dec 15, 2007·Nature Reviews. Microbiology·James C SacchettiniJoel S Freundlich
May 5, 2009·Nature Medicine·Nicolas WillandAlain R Baulard
Mar 4, 2011·Future Microbiology·Roberta Olmo PinheiroElizabeth Pereira Sampaio
Dec 23, 2011·Vaccine·Manjunatha M VenkataswamySteven A Porcelli
Jul 19, 2012·The Journal of Infectious Diseases·Kelly E DooleyUNKNOWN Efficacy Subgroup, RESIST-TB
Oct 27, 2012·The European Respiratory Journal·Dennis FalzonUNKNOWN Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB
Sep 24, 2014·Antimicrobial Agents and Chemotherapy·Nicholas A DillonAnthony D Baughn
Dec 3, 2014·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Ted CohenMatteo Zignol

❮ Previous
Next ❯

Citations

Sep 1, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Do-Hee KimBong-Jin Lee
May 29, 2016·Cold Spring Harbor Perspectives in Medicine·Alice L Erwin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.